Cervical cancer is one of the most common cancers among women in Togo. This disease represents a major public health challenge due to its impact on the female population and the need to improve prevention and treatment strategies.
According to data from the Ministry of Health, cervical cancer is the second leading cause of cancer deaths among women. Each year, several hundred new cases are diagnosed, often at an advanced stage due to the lack of regular screening and awareness.
The main risk factor for cervical cancer is persistent infection with the human papillomavirus (HPV), particularly HPV strains 16 and 18, which are responsible for the majority of cases. Other risk factors include:
Regular screening by cervical-vaginal smear (Pap test) is crucial to detect precancerous lesions and treat them before they develop into cancer. However, access to screening remains limited in Togo, particularly in rural areas.
HPV vaccination is also a key prevention strategy. The Togolese government, in partnership with international organizations, has launched vaccination campaigns targeting young girls before they enter into sexual activity.
Treatment for cervical cancer depends on the stage of the disease. In early stages, options include surgery and radiation therapy. In advanced stages, chemotherapy may be used. However, Togo faces significant challenges in terms of access to treatments, adequate medical infrastructure and qualified health personnel.
Awareness and education play a crucial role in the fight against cervical cancer. Awareness campaigns are organized to inform women about the importance of regular screening and vaccination. Efforts to integrate cervical cancer education into school and community programs are also underway.
The National Institute of Hygiene will launch a major free campaign from June 13 to 15 for women aged 25 to 50.
